# Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

> **NCT06419439** · PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 44 (estimated)

## Conditions studied

- Chronic Low Back Pain
- Depression

## Interventions

- **DRUG:** Ketamine hydrochloride
- **BEHAVIORAL:** Minimally Enhanced Usual Care
- **BEHAVIORAL:** Brief narrative intervention

## Key facts

- **NCT ID:** NCT06419439
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2028-12-01
- **Final completion:** 2029-06-30
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419439, "Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06419439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*